Grace TherapeuticsGRCE
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 20 institutions reported holding Grace Therapeutics Inc. (GRCE) in their 13F filings, up 3 from Q1 2025. 4 opened new positions and 1 sold out. The largest holders were Nantahala Capital Management, LLC ($3.5M), AIGH Capital Management LLC ($3.4M) and Bank of America Corp. ($1.5M). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Grace Therapeutics Inc.
- CUSIP
- 00439U104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $67K |
| Exits | 1 | $34 |
All 13F filers, Q1 2025 → Q2 2025: 176,305 shares bought and 383,489 shares sold, net −207,184 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Nantahala Capital Management, LLC | 0.25% | No change | 1,178,203 | $3.5M |
| AIGH Capital Management LLC | 1.57% | Reduce -14.7% | 1,128,497 | $3.4M |
| Bank of America Corp. | 0.00% | No change | 494,698 | $1.5M |
| Vanguard Group Inc. | 0.00% | Add +60.2% | 409,100 | $1.2M |
| Stonepine Capital Management, LLC | 0.86% | Reduce -0.7% | 292,500 | $869K |
| ADAR1 Capital Management, LLC | 0.09% | Reduce -48.6% | 176,627 | $525K |
| Palumbo Wealth Management LLC | 0.04% | Add +5.5% | 48,541 | $144K |
| Citadel Advisors | 0.00% | Reduce -10.5% | 34,382 | $102K |
| Renaissance Technologies | 0.00% | Reduce -34.5% | 27,625 | $82K |
| Millington Financial Advisors, LLC | 0.03% | New | 20,000 | $67K |
| National Bank of Canada | 0.00% | Reduce -0.1% | 2,716 | $8K |
| Morgan Stanley | 0.00% | No change | 1,848 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -60.6% | 1,351 | $4K |
| Royal Bank of Canada | 0.00% | No change | 543 | $2K |
| Activest Wealth Management | 0.00% | No change | 104 | $309 |
| SBI Securities Co., Ltd. | 0.00% | No change | 101 | $300 |
| Steward Partners Investment Advisory, LLC | 0.00% | New | 41 | $122 |
| Jones Financial Companies LLLP | 0.00% | New | 29 | $86 |
| Citigroup Inc. | 0.00% | New | 1 | $3 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 1 | $3 |
"% of holder's portfolio" is GRCE's weight in each manager's 13F, not the share of Grace Therapeutics Inc. the manager owns.